Applied Biosystems has appointed Masahide Habu as president of ABI Japan. Habu will manage approximately 280 employees as the overseer of ABI’s Japanese operations.
Prior to becoming president of ABI’s Japanese division, Habu was director of sales and marketing at ABI for one year. Before that, he was general manager of Kodak Professional’s Japan region, and vice president of health sciences for the Asia and Pacific Region at Kodak.
Mark Stevenson, the former president and general manager of ABI Japan has been appointed to division president of applied markets at ABI.
Jerry Williamson has been appointed as the new president of Biacore, replacing Thomas Wida, who is leaving the company, Biacore International said last week.
Williamson joins the Uppsala, Sweden-based company from Beacon BioPartners, a consultancy focusing on the life sciences sector. Prior to that, he was the president of Pyrosequencing.
Susan Lindquist will resign as president of the Whitehead Institute to focus on her laboratory and research, effective around Nov. 1, said the Institute’s board of directors in a statement last week. Lindquist’s laboratory focuses on protein folding and stress response research.
Arthur Mandell has become president and CEO of Cellective Therapeutics. In the past, Mandell was a senior vice president and chief business officer at Human Genome Sciences.